These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7590125)

  • 1. Insulinotropic action of (2S)-2-benzyl-3-(cis-hexahydro-2-isoindolinylcarbonyl) propionate. I. Secretory and cationic aspects.
    Malaisse WJ; Sato F
    Gen Pharmacol; 1995 Oct; 26(6):1313-8. PubMed ID: 7590125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel rapid- and short-acting hypoglycemic agent, a calcium(2s)-2-benzyl-3-(cis-hexahydro-2-isoindolinylcarbonyl) propionate (KAD-1229) that acts on the sulfonylurea receptor: comparison of effects between KAD-1229 and gliclazide.
    Ohnota H; Koizumi T; Tsutsumi N; Kobayashi M; Inoue S; Sato F
    J Pharmacol Exp Ther; 1994 May; 269(2):489-95. PubMed ID: 8182516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulinotropic action of (2S)-2-benzyl-3-(cis-hexahydro-2-isoindolinylcarbonyl) propionate. II. Ionophoretic and conformational aspects.
    Malaisse WJ; Nadi AB; Malaisse-Lagae F; Sato F; Lins L; Brasseur R
    Gen Pharmacol; 1995 Oct; 26(6):1319-25. PubMed ID: 7590126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro insulinotropic action of a new non-sulfonylurea hypoglycemic agent, calcium (2s)-2-benzyl-3-(cis-hexahydro-2-isoindolinyl-carbonyl) propionate dihydrate (KAD-1229), in rat pancreatic B-cells.
    Ohnota H; Kobayashi M; Koizumi T; Katsuno K; Sato F; Aizawa T
    Biochem Pharmacol; 1995 Jan; 49(2):165-71. PubMed ID: 7840793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normalization of impaired glucose tolerance by the short-acting hypoglycemic agent calcium (2S)-2-benzyl-3-(cis-hexahydro-2-isoindolinylcarbonyl)propionate dihydrate (KAD-1229) in non-insulin-dependent diabetes mellitus rats.
    Ohnota H; Koizumi T; Kobayashi M; Momose Y; Sato F
    Can J Physiol Pharmacol; 1995 Jan; 73(1):1-6. PubMed ID: 7600439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of repaglinide upon nutrient metabolism, biosynthetic activity, cationic fluxes and insulin release in rat pancreatic islets.
    Louchami K; Jijakli H; Sener A; Malaisse WJ
    Res Commun Mol Pathol Pharmacol; 1998 Feb; 99(2):155-68. PubMed ID: 9583090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rapid- and short-acting hypoglycemic agent KAD-1229 improves post-prandial hyperglycemia and diabetic complications in streptozotocin-induced non-insulin-dependent diabetes mellitus rats.
    Ohnota H; Kitamura T; Kinukawa M; Hamano S; Shibata N; Miyata H; Ujiie A
    Jpn J Pharmacol; 1996 Aug; 71(4):315-23. PubMed ID: 8886929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of the insulinotropic effect of the novel antihyperglycemic agent KAD-1229 using HIT T15 cells, a hamster's insulinoma cell line.
    Ichikawa K; Yamato T; Tsuji A; Ojima K; Kusama H; Kojima M
    Arzneimittelforschung; 2002; 52(8):605-9. PubMed ID: 12236048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulinotropic action of meglitinide analogs: concentration-response relationship and nutrient dependency.
    Bakkali-Nadi A; Malaisse-Lagae F; Malaisse WJ
    Diabetes Res; 1994; 27(2):81-7. PubMed ID: 7671557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cationic determinants of D-fructose insulinotropic action.
    Jijakli H; Malaisse WJ
    Acta Diabetol; 2000 Mar; 37(1):27-32. PubMed ID: 10928233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression by 2-ketoisocaproate of the insulinotropic action of hypoglycemic sulfonylureas.
    Malaisse WJ; Mathias PC; Malaisse-Lagae F; Sener A
    Res Commun Chem Pathol Pharmacol; 1985 Feb; 47(2):265-84. PubMed ID: 3922019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a non-sulphonylurea hypoglycaemic agent, KAD-1229 on hormone secretion in the isolated perfused pancreas of the rat.
    Kinukawa M; Ohnota H; Ajisawa Y
    Br J Pharmacol; 1996 Apr; 117(8):1702-6. PubMed ID: 8732279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a novel hypoglycemic agent, KAD-1229 on glucose metabolism and fructose-2,6-bisphosphate content in isolated hepatocytes of normal rats.
    Nakashima E; Nakamura J; Koh N; Sakakibara F; Hamada Y; Hotta N
    Diabetes Res Clin Pract; 1996 Sep; 34(1):13-22. PubMed ID: 8968686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the meglitinide analog S21403 on cationic fluxes and insulin release in perifused rat pancreatic islets exposed to a high concentration of D-glucose.
    Louchami K; Jijakli H; Malaisse WJ
    Pharmacol Res; 1999 Sep; 40(3):297-300. PubMed ID: 10479476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretory, biosynthetic and cationic responses to 2-(N-PHENYL-INDOYL)IMIDAZOLE in rat pancreatic islets.
    Louchami K; Laghmich A; Jijakli H; Mest H; Malaisse WJ
    Pharmacol Res; 1998 Oct; 38(4):305-10. PubMed ID: 9774494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of 1,1-dimethyl-2-[2-morpholinophenyl]guanidine fumarate on pancreatic islet function.
    Louchami K; Jijakli H; Sener A; Jones RB; Malaisse WJ
    Eur J Pharmacol; 1998 Jul; 352(2-3):289-97. PubMed ID: 9716366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociation between the potency and reversibility of the insulinotropic action of two meglitinide analogues.
    Jijakli H; Ulusoy S; Malaisse WJ
    Pharmacol Res; 1996; 34(3-4):105-8. PubMed ID: 9051699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of ATP-sensitive K+ channel by a non-sulfonylurea compound KAD-1229 in a pancreatic beta-cell line, MIN 6 cell.
    Mogami H; Shibata H; Nobusawa R; Ohnota H; Satou F; Miyazaki J; Kojima I
    Eur J Pharmacol; 1994 Nov; 269(3):293-8. PubMed ID: 7895769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulinotropic action of meglitinide analogues: modulation by an activator of ATP-sensitive K+ channels and high extracellular K+ concentrations.
    Malaisse WJ
    Pharmacol Res; 1995 Sep; 32(3):111-4. PubMed ID: 8745339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of glucose-induced insulin release by 3-O-methyl-D-glucose: enzymatic, metabolic and cationic determinants.
    Sener A; Scruel O; Louchami K; Jijakli H; Malaisse WJ
    Mol Cell Biochem; 1999 Apr; 194(1-2):133-45. PubMed ID: 10391133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.